These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potential clinical application of novel cardiac biomarkers for acute myocardial infarction. Nursalim A; Suryaatmadja M; Panggabean M Acta Med Indones; 2013 Jul; 45(3):240-50. PubMed ID: 24045397 [TBL] [Abstract][Full Text] [Related]
3. Novel biomarkers for cardiovascular risk prediction. Wang J; Tan GJ; Han LN; Bai YY; He M; Liu HB J Geriatr Cardiol; 2017 Feb; 14(2):135-150. PubMed ID: 28491088 [TBL] [Abstract][Full Text] [Related]
4. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676 [TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction. Behnes M; Papassotiriou J; Walter T; Fiedler E; Sauer T; Lang S; Elmas E; Hoffmann U; Borggrefe M; Brueckmann M Clin Chem Lab Med; 2008; 46(2):204-11. PubMed ID: 18076360 [TBL] [Abstract][Full Text] [Related]
6. Rapidly rule out acute myocardial infarction by combining copeptin and heart-type fatty acid-binding protein with cardiac troponin. Jacobs LH; van Borren M; Gemen E; van Eck M; van Son B; Glatz JF; Daniels M; Kusters R Ann Clin Biochem; 2015 Sep; 52(Pt 5):550-61. PubMed ID: 25732130 [TBL] [Abstract][Full Text] [Related]
7. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Sabatine MS; Morrow DA; de Lemos JA; Gibson CM; Murphy SA; Rifai N; McCabe C; Antman EM; Cannon CP; Braunwald E Circulation; 2002 Apr; 105(15):1760-3. PubMed ID: 11956114 [TBL] [Abstract][Full Text] [Related]
11. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study. Narayan H; Dhillon OS; Quinn PA; Struck J; Squire IB; Davies JE; Ng LL Clin Sci (Lond); 2011 Jul; 121(2):79-89. PubMed ID: 21309746 [TBL] [Abstract][Full Text] [Related]
12. Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome. Widera C; Pencina MJ; Bobadilla M; Reimann I; Guba-Quint A; Marquardt I; Bethmann K; Korf-Klingebiel M; Kempf T; Lichtinghagen R; Katus HA; Giannitsis E; Wollert KC Clin Chem; 2013 Oct; 59(10):1497-505. PubMed ID: 23818444 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers in patients with Takotsubo cardiomyopathy compared to patients with acute anterior ST-elevation myocardial infarction. Højagergaard MA; Hassager C; Christensen TE; Bang LE; Gøtze JP; Ostrowski SR; Holmvang L; Frydland M Biomarkers; 2020 Mar; 25(2):137-143. PubMed ID: 31902247 [No Abstract] [Full Text] [Related]
14. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score. Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055 [TBL] [Abstract][Full Text] [Related]
15. Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study. Ricci F; Di Scala R; Massacesi C; Di Nicola M; Cremonese G; De Pace D; Rossi S; Griffo I; Cataldo I; Martinotti S; Rotondo D; Jaffe AS; Zimarino M; De Caterina R Am J Med; 2016 Jan; 129(1):105-14. PubMed ID: 26169889 [TBL] [Abstract][Full Text] [Related]
16. Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era. Onda T; Inoue K; Suwa S; Nishizaki Y; Kasai T; Kimura Y; Fukuda K; Okai I; Fujiwara Y; Matsuoka J; Sumiyoshi M; Daida H Int J Cardiol; 2016 Sep; 219():180-5. PubMed ID: 27327504 [TBL] [Abstract][Full Text] [Related]
17. Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation. Sanchis J; Bosch X; Bodí V; Bellera N; Núñez J; Benito B; Ordóñez J; Consuegra L; Heras M; Llècer A Heart; 2008 Mar; 94(3):311-5. PubMed ID: 17639094 [TBL] [Abstract][Full Text] [Related]
18. [Natriuretic peptides and multimarker approach to risk stratification of patients with acute coronary syndromes]. Matunović R; Stojanović A; Mijailović Z; Cosić Z Med Pregl; 2006; 59(5-6):248-52. PubMed ID: 17039908 [TBL] [Abstract][Full Text] [Related]